In 2024, Germany leads European Higher Education Expenditure on R&D in Medical and Health Sciences with 55.2 million euros, routinely surpassing other countries. The Netherlands follows with 19 million euros, while Italy and Spain show significant investments at 9.89 and 8.89 million euros, respectively. Emerging contributors like Slovakia, Lithuania, and Latvia, despite smaller absolute values, demonstrated rapid growth in 2023 with variations of 10.07%, 14.96%, and 9.72% respectively. Over the last five years, the compound annual growth rates (CAGR) highlight significant upward trends, emphasizing a strong interest in R&D within the medical and health sectors.
Future trends to watch include:
- Increasing collaborations across borders in medical research.
- The potential growth of Eastern European countries in R&D investments.
- Technological advancements influencing R&D expenditures.
- A focus on addressing public health challenges driving R&D choices.
Top countries in Higher Education Expenditure on R&D in Medical and Health Sciences Share by Country (Million Euros)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 55.2 | 2023 | +3.51% | +4.91% | View data |
| 2 | 2 Netherlands | 19 | 2023 | +2.67% | +3.94% | View data |
| 3 | 3 Italy | 9.89 | 2023 | +1.74% | +1.56% | View data |
| 4 | 4 Spain | 8.89 | 2023 | +5.46% | +6.55% | View data |
| 5 | 5 Finland | 3.79 | 2023 | +2.12% | +2.7% | View data |
| 6 | 6 Portugal | 1.85 | 2023 | +2.78% | +3.68% | View data |
| 7 | 7 Slovakia | 0.44 | 2023 | +3.49% | +10.07% | View data |
| 8 | 8 Lithuania | 0.33 | 2023 | +3.18% | +14.96% | View data |
| 9 | 9 Slovenia | 0.26 | 2023 | +3.11% | +9.63% | View data |
| 10 | 10 Estonia | 0.23 | 2023 | +3.33% | +5.3% | View data |
